Region: Global
Category: Diagnostics

Global Diagnostics

(6,906 reports matching your criteria)
  • POC Lipid Testing

    ... at a CAGR of 3.2% over the analysis period 2024-2030. Hyperlipidemia, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$97.0 Million by the end of the ... Read More

  • Drug Screening

    ... CAGR of 16.7% over the analysis period 2024-2030. Drug Screening Products, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$16.7 Billion by the end of the ... Read More

  • 2025 Global Fluoroscopy Equipment Market Industry (2031 Outlook)

    ... a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology analysis, ... Read More

  • Flat Panel Detector (FPD) based X-Ray for Cone Beam Computed Tomography (CBCT)

    ... (CBCT) estimated at US$3.1 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Orthopedics, one of the segments analyzed in ... Read More

  • Optical Coherence Tomography (OCT) for Ophthalmology

    ... reach US$1.1 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Conventional OCT Systems, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and ... Read More

  • Medical Connectors

    ... CAGR of 5.5% over the analysis period 2024-2030. Hospital & Clinics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.7 Billion by the end of the ... Read More

  • Medical Imaging Information Systems

    ... 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$390.1 Million by the ... Read More

  • Microfluidic Device Systems

    ... at a CAGR of 19.3% over the analysis period 2024-2030. In-vitro diagnostics, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$13.3 Billion by the end of ... Read More

  • Near Infrared Imaging

    ... at a CAGR of 14.8% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$1.7 Billion by the end of the ... Read More

  • Medical Radiation Detection, Monitoring and Safety

    ... reach US$1.4 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Personal Dosimeters, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More

  • Optical Imaging Techniques

    ... at a CAGR of 10.1% over the analysis period 2024-2030. Optical Coherence Tomography, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$3.2 Billion by the end ... Read More

  • Veterinary Molecular Diagnostics

    ... at a CAGR of 7.5% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$342.8 Million by the end ... Read More

  • Veterinary Ultrasound Scanners

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Portable Ultrasound Scanners, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$327.4 Million by the end ... Read More

  • Rapid Antigen Detection Tests

    ... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.4% CAGR The Rapid Antigen Detection Tests market ... Read More

  • Cell Analysis

    ... CAGR of 5.5% over the analysis period 2024-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$10.3 Billion by the end of the ... Read More

  • Clinical Risk Grouping Solutions

    ... 2030, growing at a CAGR of 13.8% over the analysis period 2024-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$1.1 Billion ... Read More

  • Hematology Instruments and Reagents

    ... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the ... Read More

  • Spectroscopy Equipment and Accessories

    ... 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Molecular Spectroscopy, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$7.6 Billion by the ... Read More

  • Automated Blood Tube Labelers and Specimen Transport Boxes

    ... 2024, is expected to reach US$518.8 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 7.4% ... Read More

  • Cardiac POC Testing Devices

    ... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.6 Billion by ... Read More

  • Mobile Gamma Cameras

    ... at a CAGR of 4.2% over the analysis period 2024-2030. Single Head Mobile Gamma Camera, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$45.4 Million by ... Read More

  • Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2025

    ... cancer nuclear medicine diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More

  • Nuclear Medicine Radioisotope

    ... at a CAGR of 7.8% over the analysis period 2024-2030. Technetium-99m (Tc-99m), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by the end of ... Read More

  • Pneumonia Therapeutics

    ... CAGR of 6.7% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis period. ... Read More

  • In Vitro Toxicology Testing

    ... 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.2 Billion by ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings